The Foundation Fighting Blindness (FFB) announced that it has selected Benjamin Yerxa, a biotechnology and drug development executive, as its Chief Executive Officer, effective immediately.
Approval of the gene therapy will allow treatment for people with vision-loss due to RPE65 mutations and will help advance other investigational studies with potential to help millions, FFB tells the Committee.
The Foundation Fighting Blindness (FFB), the world’s leading private funder of research on preventions, treatments and cures for vision loss due to inherited retinal diseases is accepting applications for its next round of funding grants to be awarded May 2018.
The first patient has been enrolled in a four-year natural history study of people with mutations in the USH2A gene.
The National Center for Excellence in Fighting Blindness, a Gund-Harrington Initiative, has opened its fourth annual Gund-Harrington Scholar Award competition to support innovative research efforts that seek to prevent, treat or cure blindness.
A newly established French company, SparingVision, has won the 2017 i-Lab Grand Prize recognizing new and innovative companies. The i-Lab competition is organized by the French Ministry of Higher Education, Research and Innovation and Bpifrance (BPI).
The Foundation Fighting Blindness (FFB) today announced $6 million in new research funding across a spectrum of potential preventions, treatments and cures for inherited retinal diseases including retinitis pigmentosa and macular degeneration.
The Foundation Fighting Blindness (FFB), the world’s leading private funder of research aimed at preventing, treating and curing blindness caused by inherited retinal diseases hosted its annual Fashion and Finance Ball on Tuesday, May 16 at New York’s Plaza Hotel. To date, the dinner has raised $425,000 for inherited retinal disease research and donations are continuing to be made.
The Foundation Fighting Blindness (FFB), the world’s leading private funder of research aimed at preventing, treating and curing blindness caused by inherited retinal diseases will hold its Fashion and Finance Ball on Tuesday, May 16 at New York’s Plaza Hotel. A cocktail reception and silent auction will open the evening at 6:00 p.m.; the dinner and awards program will begin at 7:00 p.m.
The Association for Research in Vision and Ophthalmology (ARVO)’s annual conference – Baltimore, May 7-11 – gathers the field’s leading researchers to report on advancements in vision science including the search for cures for retinal degenerative diseases.